Skip to main content
Acta Crystallographica Section F: Structural Biology and Crystallization Communications logoLink to Acta Crystallographica Section F: Structural Biology and Crystallization Communications
. 2005 Nov 24;61(Pt 12):1081–1083. doi: 10.1107/S1744309105037541

Expression, purification, crystallization and preliminary X-ray diffraction analysis of an essential lipoprotein implicated in cell-wall biosynthesis in Mycobacteria

Zara Marland a,b,, Travis Beddoe a,b,, Leyla Zaker-Tabrizi a,b, Ross L Coppel b,c, Paul K Crellin b,c,*, Jamie Rossjohn a,b,*
PMCID: PMC1978156  PMID: 16511240

A lipoprotein implicated in mycobacterial cell-wall biosynthesis, LpqW, was expressed in E. coli. Crystals were obtained that diffracted to 2.4 Å resolution.

Keywords: Mycobacterium tuberculosis, LpqW, lipoproteins

Abstract

Mycobacterium tuberculosis is a renewed cause of devastation in the developing world. Critical to the success of this re-emerging pathogen is its unusual waxy cell wall, which is rich in rare components including lipoarabinomannan (LAM) and its precursors, the phosphatidylinositol mannosides (PIMs). Balanced synthesis of these related glycolipids is intrinsic to both cell-wall integrity and virulence in M. tuberculosis and presents a promising, albeit poorly defined, therapeutic target. Here, the expression, purification and crystallization of an essential 600-­amino-acid lipoprotein, LpqW, implicated in this process are reported. Crystals of LpqW were grown using 20–24%(w/v) PEG 4000, 8–­16%(v/v) 2-­propanol, 100 mM sodium citrate pH 5.5 and 10 mM DTT. A complete data set was collected at 2.4 Å using synchrotron radiation on a crystal belonging to space group C222, with unit-cell parameters a = 188.57, b = 312.04, c = 104.15 Å. Structure determination is under way.

1. Introduction

Tuberculosis (TB) claims the lives of over two million people each year, with more than a quarter of deaths in Africa alone. The epidemic has rapidly worsened in this region over the past 15 y owing to poor compliance with TB treatment programs and widespread coincidence of HIV/AIDS. This has also fostered rampant multi-drug resistance in the causative bacterium, Mycobacterium tuberculosis, and intensified the need to develop new drugs against this agent. The unusual waxy cell wall of M. tuberculosis is essential to its survival and pathogenicity and thus holds significant potential as a target for such drugs.

The cell wall of Mycobacteria spp. consists of a peptidoglycan core with covalently linked layers of arabinogalactan and mycolic acid (Brennan & Nikaido, 1995). This complex structure forms a hydrophobic barrier, complemented by glycolipids including lipoarabinomannan (LAM) and its abundant precursors, the phosphatidylinositol mannosides (PIMs; Brennan & Nikaido, 1995). By actively blocking maturation of phagosomes containing internalized bacilli while permitting fusion events with early endosomes, these lipoglycans are responsible for the survival and persistence of M. tuberculosis in the host macrophage (Fratti et al., 2003; Vergne et al., 2004).

PIMs consist of a phosphatidylinositol anchor glycosylated with one to six mannose residues (PIM1–PIM6) and modified by extra fatty-acyl chains. Addition of further mannose residues gives lipomannans (LMs) and these intermediates are in turn glycosylated with branching arabinose chains to form LAMs (Besra et al., 1997). Although the bifurcation of the synthesis of PIMs and LAM is not defined, it is thought to arise from the addition of either α(1–2)- or α(1–6)-linked mannose to the last common intermediate, PIM4, in the periplasmic space (Morita et al., 2004).

Recently, a putative lipoprotein comprised of 600 amino-acid residues (62.9 kDa), termed LpqW, has been implicated in controlling the divergence point of the PIMs/LAM biosynthetic pathways (Kovacevic et al., 2005). Moreover, saturation mutagenesis studies revealed that the corresponding gene (Rv1166c) was essential to M. tuberculosis (Sassetti et al., 2003), suggesting that different mycobacterial species exhibit subtleties in their dependencies on the PIMs/LAM metabolic machinery.

To delineate the structure and function of LpqW, the soluble ectodomain of the M. smegmatis homologue was expressed in Escherichia coli. Crystals of LpqW were obtained that diffract to 2.4 Å resolution. The details of the expression, purification, crystallization and preliminary diffraction analysis are reported here.

2. Materials and methods

2.1. Cloning of LpqW ectodomain

The lpqW gene was PCR amplified from M. smegmatis mc2155 genomic DNA using primers A (5′-GGAATTCCATATGTGCACGGTGAGCCCGCCTCCC-3′) and B (5′-GCCGAATTCTACTTGGTCTTCGTCCAGTC-3′) and Proofstart DNA Polymerase (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The primers were designed to allow expression of lpqW without the putative signal peptide such that the N-terminal amino acid of the recombinant protein, after the vector-derived leader sequence (MGSSH6SSGLVPRGSHM), is the cysteine to which the lipid is likely to be attached in mycobacteria. Restriction-enzyme sites for NdeI and EcoRI (bold) were incorporated into primers A and B, respectively, for cloning purposes. The PCR product was purified using the UltraClean 15 DNA Purification Kit (Mo Bio Laboratories, CA, USA). NdeI/EcoRI-digested PCR product was then cloned into NdeI/EcoRI-digested pET28b (Novagen, WI, USA). A positive clone was sequenced using T7 promoter and terminator primers. The resulting construct, encoding a 620-amino-acid protein with a N-­terminal hexahistidine tag, was used to transform the E. coli BL21 strain.

2.2. Protein expression and purification

BL21 cells were grown at 310 K to an OD600 of 0.5 in Luria–Bertani medium containing kanamycin (34 µg ml−1). Protein expression was induced by the addition of 0.5 mM isopropyl-β-d-thiogalactopyranoside. Cells were harvested after 4 h incubation by centrifugation at 6000g for 20 min at 277 K, resuspended in lysis buffer (20 mM Tris–HCl pH 8.0, 50 mM NaCl, 0.2 mM phenylmethylsulfonyl fluoride, 10 mM β-mercaptoethanol) and homogenized by passage through a French press (Avestin, Ottawa, Canada). Lysates were centrifuged at 10 000g for 15 min at 277 K and applied onto a 2 ml column of Ni–NTA agarose (Qiagen) in equilibration buffer (20 mM imidazole, 20 mM Tris–HCl pH 8.0, 100 mM NaCl). The column was washed with five column volumes of equilibration buffer and LpqW was eluted in 200 mM imidazole, 20 mM Tris–HCl pH 8.0, 100 mM NaCl. The protein was further purified by chromatography on a calibrated 16/60 Superdex 200 prep-grade column (Amersham-Pharmacia, Uppsala, Sweden) in 20 mM Tris–HCl pH 8.0, 100 mM NaCl, 2 mM dithiothreitol (DTT), concentrated and quantified by spectrophotometric analysis.

2.3. Crystallization and data collection

Crystallization experiments were performed at room temperature by the hanging-drop vapour-diffusion technique. Solutions of purified LpqW were concentrated to 10–15 mg ml−1 (in 20 mM Tris–HCl pH 8.0, 100 mM NaCl, 2 mM DTT) and screened in the commercially available PEG/Ion Screen and Crystal Screens 1 and 2 (Hampton Research, CA, USA).

Diffraction-quality crystals of LpqW were grown by mixing equal volumes of 20 mg ml−1 protein solution and reservoir buffer consisting of 20–24%(w/v) polyethylene glycol (PEG) 4000, 8–16%(v/v) 2-propanol, 100 mM sodium citrate pH 5.5, 10 mM DTT. Crystals were equilibrated in cryoprotectant solution comprising 25%(w/v) PEG 4000, 12%(v/v) 2-propanol, 100 mM Tris pH 7.0 for 12 h and flash-cooled directly in liquid nitrogen prior to diffraction analysis.

A complete native data set was collected at the BioCars beamline (Advanced Photon Source, Chicago) using a Quantum 4 charge-coupled device detector. The native data set comprised 260 images (0.5° oscillation, 5 s exposure per oscillation). Diffraction data were processed and analysed using the HKL package (Table 1) (Otwinowski & Minor, 1997).

Table 1. Data-collection statistics.

The values in parentheses are for the highest resolution bin (approximate interval 0.1 Å).

Temperature (K) 100
X-ray source APS, BioCars 14-BM-C
Detector Quantum 4 CCD
Space group C222
Unit-cell parameters (Å) a = 188.6, b = 312.0, c = 104.1
Resolution (Å) 2.4
Total No. of observations 439493
No. of unique observations 115857
Multiplicity 3.8
Data completeness (%) 97.1 (93.0)
No. of data > 2σ(I) 91071 (4632)
I/σ(I)〉 17.9 (2.1)
Rmerge (%) 8.1 (57.7)

R merge = Inline graphic Inline graphic.

3. Results and discussion

3.1. Protein expression and purification

Following cell lysis, the majority of the LpqW protein was in soluble form. Protein eluted from the Ni–NTA chromatography medium using 200 mM imidazole was approximately 80% pure, as estimated by SDS–PAGE. A polypeptide of approximate molecular weight 65 kDa was observed that matched the predicted size (65.1 kDa) of LpqW including an N-terminal hexahistidine tag and the additional residues encoded by pET28b. Yields of pure protein were typically 6 mg per litre of culture. The protein was applied directly onto a calibrated S200 size-exclusion column. The majority of LpqW eluted from the column in monomeric form (Fig. 1) and was concentrated to 20 mg ml−1 for crystallization trials.

Figure 1.

Figure 1

Reducing SDS–PAGE of LpqW purified using Ni–NTA and size-exclusion chromatography (lane 1). The positions of the molecular-weight markers are indicated in lane 2. The gel was stained using Coomassie Brilliant Blue.

3.2. Crystallization and data collection

Crystals were obtained in two of the conditions screened and improved orthorhombic crystals grew in conditions based on Crystal Screen formulation No. 40. Freezing conditions that included a range of cryoprotectant agents at various concentrations were screened and resulted in crystals of very poor diffraction quality [high mosaicity (greater than 1.5°) and low resolution (less than 4 Å)]. However, single-step dehydration in reservoir buffer containing an increased concentration (total 25%) of the precipitant PEG 4000 for 12 h, followed by flash-cooling directly in liquid nitrogen, extended the diffraction limit of the crystals with a much reduced mosaicity (less than 0.6°).

Crystals of LpqW that grew in the optimized condition (Fig. 2) reproducibly diffracted to beyond 3 Å in-house. A complete native data set to 2.4 Å resolution was collected on a crystal belonging to the orthorhombic space group C222, with unit-cell parameters a = 188.57, b = 312.04, c = 104.15 Å. Assuming the presence of three monomers per asymmetric unit, the calculated V M (Matthews, 1968) and solvent content for the native crystal were 3.9 Å3 Da−1 and 68% respectively. Nonetheless, there is no biochemical evidence to suggest that LpqW functions as an oligomer.

Figure 2.

Figure 2

Diffraction-quality crystal of LpqW.

The three-dimensional structure of LpqW will provide insight into the regulatory mechanisms that ensure balanced synthesis of PIMs and LAM in the cell wall of M. tuberculosis. LpqW has been proposed to function at the point where the biosynthetic pathways for these molecules bifurcate. As the maintenance of this equilibrium is important for both cell-wall integrity and pathogenesis, this will not only serve intrinsic interest in mycobacterial cell-wall biosynthesis, but also potentially elucidate targets for and thus inform the design of novel anti-tuberculosis drugs. Structure determination is under way.

Acknowledgments

The Australian Research Council supported this work.

References

  1. Besra, G. S., Morehouse, C. B., Rittner, C. M., Waechter, C. J. & Brennan, P. J. (1997). J. Biol. Chem.272, 18460–18466. [DOI] [PubMed] [Google Scholar]
  2. Brennan, P. J. & Nikaido, H. (1995). Annu. Rev. Biochem.64, 29–63. [DOI] [PubMed] [Google Scholar]
  3. Fratti, R. A., Chua, J., Vergne, I. & Deretic, V. (2003). Proc. Natl Acad. Sci. USA, 100, 5437–5442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kovacevic, S., Anderson, D., Morita, Y. S., Patterson, J., Haites, R., Coppel, R., McConville, M. J. & Billman-Jacobe, H. (2005). Submitted.
  5. Matthews, B. W. (1968). J. Mol. Biol.33, 491–497. [DOI] [PubMed] [Google Scholar]
  6. Morita, Y. S., Patterson, J. H., Billman-Jacobe, H. & McConville, M. J. (2004). Biochem. J.378, 589–597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol.276, 307–326. [DOI] [PubMed]
  8. Sassetti, C. M., Boyd, D. H. & Rubin, E. J. (2003). Mol. Microbiol.48, 77–84. [DOI] [PubMed] [Google Scholar]
  9. Vergne, I., Fratti, R. A., Hill, P. J., Chua, J., Belisle, J. & Deretic, V. (2004). Mol. Biol. Cell, 15, 751–760. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Acta Crystallographica Section F: Structural Biology and Crystallization Communications are provided here courtesy of International Union of Crystallography

RESOURCES